Possible Bearish Signals With Charles River Laboratories International Insiders Disposing Stock
Possible Bearish Signals With Charles River Laboratories International Insiders Disposing Stock
Over the past year, many Charles River Laboratories International, Inc. (NYSE:CRL) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.
在過去一年中,許多查爾斯河實驗室國際股份有限公司(NYSE:CRL)的股東出售了公司的大部分股份,這可能引起了投資者的興趣。分析內部交易時,了解股東是否買入要比了解他們是否賣出更有價值,因爲後者傳遞了不明確的信息。但如果幾位內部人士在特定時間段內出售股票,則股東應該仔細觀察。
While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.
雖然在長期投資方面內部交易並非最重要的事情,但完全忽略內部交易是愚蠢的。
The Last 12 Months Of Insider Transactions At Charles River Laboratories International
查爾斯河實驗室國際的最近12個月內部交易
Over the last year, we can see that the biggest insider sale was by the Corporate Executive VP & Chief People Officer, Victoria Creamer, for US$1.3m worth of shares, at about US$254 per share. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$222. So it is hard to draw any strong conclusion from it.
過去一年中,我們可以看到企業執行執行副總裁兼首席人民官員Victoria Creamer最大的內部銷售額爲130萬美元,每股價格約爲254美元。雖然內部銷售是負面的,但對我們來說,如果股票以較低價格出售,則更爲負面。讓人有些安慰的是,這次銷售的價格遠高於目前的股價,即222美元。因此,很難從中得出任何明確的結論。
In the last twelve months insiders purchased 7.94k shares for US$1.4m. But insiders sold 26.04k shares worth US$6.2m. Over the last year we saw more insider selling of Charles River Laboratories International shares, than buying. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
在過去的十二個月中,內部人士購買了0.794萬股,價值140萬美元。但內部人員出售了價值620萬美元的2.604萬股。在過去一年中,查爾斯河實驗室國際的內部人員出售了更多的股份,而不是購買。下面的圖表顯示了過去一年中內部交易(公司和個人)。通過點擊下面的圖表,您可以查看每個內部交易的詳細信息!
![big](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240726/0-451633c97687730e1dc14c95291ae678-0-08eaed0448ed0150dc924c65e2748da8.png/big)
If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.
如果您和我一樣,您就不會錯過這個免費的小盤股票列表,這些股票不僅被內部人士購買,而且估值也很有吸引力。
Charles River Laboratories International Insiders Are Selling The Stock
查爾斯河實驗室國際的內部人士正在出售股票
The last three months saw significant insider selling at Charles River Laboratories International. Specifically, Corporate Executive Vice President of Corporate Development & Strategy Joseph LaPlume ditched US$296k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.
過去三個月,查爾斯河實驗室國際的內部人員大量出售股票。具體來說,企業執行副總裁兼企業發展與戰略Joseph LaPlume在此期間拋售了價值29.6萬美元的股票,我們沒有記錄任何購買行爲。總的來說,這讓我們有點謹慎,但這不是一切的全部。
Does Charles River Laboratories International Boast High Insider Ownership?
查爾斯河實驗室國際擁有高內部所有權嗎?
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Charles River Laboratories International insiders own 1.1% of the company, currently worth about US$128m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
測試公司領導者與其他股東之間的一致性的另一種方法是查看他們擁有多少股份。高內部所有權通常使公司領導層更注意股東利益。查爾斯河實驗室國際的內部人士擁有該公司的1.1%,根據最近的股價,目前價值約爲1.28億美元。這種重要的內部所有權通常增加了公司依據所有股東的利益運行的機會。
What Might The Insider Transactions At Charles River Laboratories International Tell Us?
查爾斯河實驗室國際的內部交易可能會告訴我們什麼?
An insider sold stock recently, but they haven't been buying. Zooming out, the longer term picture doesn't give us much comfort. It is good to see high insider ownership, but the insider selling leaves us cautious. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Charles River Laboratories International. Case in point: We've spotted 1 warning sign for Charles River Laboratories International you should be aware of.
內部人士最近出售了股票,但他們並沒有購買。從長遠來看,情況並不令人感到安慰。看到高內部所有權是件好事,但內部人員的出售使我們持謹慎態度。除了了解正在進行的內部交易外,識別Charles River Laboratories International面臨的風險也很有益。實踐證明:我們在Charles River Laboratories International發現了一個警告標誌,您應該知道它。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
當然,您可能會在其他地方找到一項出色的投資。因此,請查看此免費的有趣公司列表。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
譯文內容由第三人軟體翻譯。